Skip to main content
. 2019 Mar 28;13:1178221819835847. doi: 10.1177/1178221819835847

Figure 3.

Figure 3.

SVR 12 and/or SVR 24 rates of HCV therapy for non-OST and OST patients according to alcohol (A) and cannabis (B) consumption (PP population). DU indicates former/current drug use and/or HCV transmission via drug abuse; LTFU, lost to follow-up; non-OST, patients without OST; NDU, no former/current drug use/other mode of HCV transmission; OST, opioid substitution therapy; PP, per protocol; SVR, sustained virological response.

P > .05 compared with OST (no significant differences).